Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Monday, October 3, 2011 - 12:37pm
tags:
Achillion, Aeterna Zentaris, Antigenics, Ariad, Amylin, Amarin, BioDelivery Sciences, Cyclacel, Geron, Dendreon, PharmAthene, Zalicus, Human Genome Sciences, Keryx, Peregrine Pharmaceuticals, SIGA technologies, YM BioSciences
Medicines Co. rises after settling lawsuit with Teva over generic version of its drug Angiomax
Yahoo/AP
Monday, October 3, 2011 - 12:33pm
tags:
generics, Angiomax, Medicines Company, anticlotting, Teva Pharmaceuticals
Galapagos inks $367M deal in back-ended discovery pact with Servier
Fierce Biotech
Monday, October 3, 2011 - 11:46am
tags:
Servier, Galapagos
EntreMed shares spike on PhII cancer data
Fierce Biotech
Monday, October 3, 2011 - 11:42am
tags:
EntreMed, ENMD-2076, ovarian cancer
Micromet Maxes Out These 2 Metrics
Motley Fool
Monday, October 3, 2011 - 11:40am
tags:
Micromet
Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss
Yahoo
Monday, October 3, 2011 - 11:15am
tags:
Qnexa, obesity, Vivus
Biotech Calendar: Key Dates for October
TheStreet.com
Monday, October 3, 2011 - 11:13am
tags:
biotech, flurosorafenib, ONYX Pharmaceuticals, Bayer, Rigel, Teva Pharmaceuticals, Biogen Idec, BG-12, Heplisav, Amgen, Dynavax, Pacira, Bristol-Myers Squibb, Dapagliflozin, EXPAREL, cabozantinib, Exelixis
GlaxoSmithKline Looks for Bolt-On Buys in India
WSJ Online
Monday, October 3, 2011 - 11:07am
tags:
GSK, India
Why Universities Are Key to the Future of Biotech
Xconomy
Monday, October 3, 2011 - 11:04am
tags:
biotech
Insurer Won’t Pay For Avastin Breast Cancer Use
Pharmalot
Monday, October 3, 2011 - 11:03am
tags:
breast cancer, Avastin, insurance, Genentech
Early Stage Biotech Financing: Fewer, Leaner, and Better?
Forbes
Monday, October 3, 2011 - 10:42am
tags:
biotech, financing
5-Star Stocks Poised to Pop: Endo Pharmaceuticals
Motley Fool
Monday, October 3, 2011 - 10:41am
tags:
Endo
Sangamo Nerve Regrowth Drug Fails Key Test
TheStreet.com
Monday, October 3, 2011 - 10:40am
tags:
nerve regrowth, Sangamo BioSciences, SB-509, diabetic neuropathy
MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer
Yahoo
Monday, October 3, 2011 - 10:39am
tags:
MedImmune, cancer immunotherapy, Pfizer, tremelimumab, AstraZeneca, CTLA-4 monoclonal antibody
Teva Broadens Platform In Japan's Growing Generics Market
Seeking Alpha
Sunday, October 2, 2011 - 12:46pm
tags:
Teva Pharmaceuticals, Kowa, generics
China Biotech Week In Review: Sinovac Begins Foray Into Animal Health Vaccine
Seeking Alpha
Sunday, October 2, 2011 - 12:45pm
tags:
Sinovac, animal health, Cardinal Health, Sanjiu Medical and Pharmaceutical, Guangdong Zhongsheng Pharma, Takeda, Merck
Mergers: (EU) Commission approves acquisition of parts of Teva by Procter & Gamble
IEWY News
Sunday, October 2, 2011 - 12:42pm
tags:
Teva Pharmaceuticals, Proctor & Gamble, M&A
Onyx Pharma submits NDA for carfilzomib in relapsed and refractory multiple myeloma
Pharmabiz
Sunday, October 2, 2011 - 12:35pm
tags:
ONYX Pharmaceuticals, Carfilzomib, proteasome inhibitors, Multiple Myeloma
The Next Big Thing in Biotech: Hep C Drugs (video)
The Street
Sunday, October 2, 2011 - 12:31pm
tags:
hepatitis C, Vertex, Pharmasset, Idenix, Inhibitex
Sangamo's Phase II Results To Be Announced Monday - Expect Good News
Seeking Alpha
Sunday, October 2, 2011 - 12:28pm
tags:
Sangamo BioSciences, SB-509, diabetic neuropathy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.